Justin Klein, MD, JD

Justin has served as a member of PhaseBio’s board of directors since December 2009. He is a healthcare-focused venture capital investor, and previously served as a partner at New Enterprise Associates. He is a member of the boards of directors of multiple emerging growth companies, including Senseonics Holdings. Previously, Justin worked for the Duke University Health System, reporting directly to the hospital CEO on health system strategy, finance and clinical service unit operations. Justin received an AB in economics and a BS in biological anthropology and anatomy from Duke University, an MD from the Duke University School of Medicine and a JD from Harvard Law School.